On a corporate action affecting ordinary shares of Seagen Inc. (SGEN)

On March 12, 2023, Seagen Inc. signed a merger agreement with Pfizer Inc. under which Pfizer Inc. will acquire Seagen Inc. for $229 in cash per share. The completion of the merger is expected on December 14, 2023. For more details, please, refer to the company’s website.

ITS Ltd. will publish separate notices on the procedures undertaken by ITS Ltd. to process this corporate action outlining how trading in these qualified investments will be carried out.